ChanAT, ArberN, BurnJ, ChiaWK, ElwoodP, HullMA, LoganRF, RothwellPM, SchrörK, BaronJA. 2012. Aspirin in the chemoprevention of colorectal neoplasia: an overview. Cancer Prev Res (Phila), 5(2):164–178.
2.
HusainSS, SzaboIL, TamawskiAS. 2002. NSAID inhibition of GI cancer growth: clinical implications and molecular mechanisms of action. Am J Gastroenterol, 97(3):542–553.
3.
KiralyO, GongG, OlipitzW, MuthupalaniS, EngelwardBP. 2015. Inflammation-induced cell proliferation potentiates DNA damage-induced mutations in vivo. PLoS Genet, 11(2):e1004901.
4.
ShalapourS, KarinM. 2015. Immunity, inflammation, and cancer: an eternal fight between good and evil. J Clin Invest, 125(9):3347–3355.
5.
Strasser-WeipplK, HigginsMJ, ChapmanJW, IngleJN, SledgeGW, BuddGT, EllisMJ, PritchardKI, ClemonsMJ, Badovinac-CrnjevicT, HanL, GelmonKA, RabaglioM, ElliottC, ShepherdLE, GossPE. 2018. Effects of celecoxib and low-dose aspirin on outcomes in adjuvant aromatase inhibitor-treated patients: CCTG MA.27. J Natl Cancer Inst, 110(9):1003–1008.
6.
WangX, ChanAT, SlatteryML, Chang-ClaudeJ, PotterJD, GallingerS, CaanB, LampeJW, NewcombPA, ZubairN, HsuL, SchoenRE, HoffmeisterM, BrennerH, Le MarchandL, PetersU, WhiteE. 2018. Influence of smoking, body mass index, and other factors on the preventive effect of nonsteroidal anti-inflammatory drugs on colorectal cancer risk. Cancer Res, 78(16):4790–4799.
